Abstract
Erucic acid, an omega-9 monounsaturated fatty acid present in Brassicaceae plants (rapeseed and mustard oils) is highly consumed by the Chinese population and according to several global survey studies, its highest levels are encountered in the Chinese women’s milk. Erucic acid is an activating ligand of the transcription factor PPARδ and an inhibitor of the transcriptional activity of PPARγ, which drive tumorigenesis of glioblastomas and medulloblastomas. In this theoretical review, we propose that erucic acid in diet may associate with the risk of brain tumors. High grade brain tumors including medulloblastomas in children and glioblastomas in adults have devastating consequences for human health and the latter tumors are practically incurable. CONCORD-3 epidemiological study recently published in 2021 revealed a low ratio of medulloblastomas in the pediatric age group and also a low ratio of glioblastomas in adults in the Chinese population. It is certain that such profound differences can not be attributed to a single genetic factor or a single nurture pattern. It is very likely that multiple hereditary, nutritional and environmental factors are responsible for these lower ratios; yet here we propose that erucic acid may be one of the contributing factors. If future epidemiological studies and animal models show antitumor activity of erucic acid regarding brain neoplasias, it can be utilized as a preventive strategy for populations possessing very high risks to develop brain tumors such as those harbouring hereditary syndromes increasing the vulnerability to develop such malignancies.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
This is not an original study; hence data supporting the information reported in the article can be found in international databases (PubMed, Web of Science, etc.) by referring to the articles listed in references below.
References
Altinoz MA, Korkmaz R (2004) NF-kappaB, macrophage migration inhibitory factor and cyclooxygenase-inhibitions as likely mechanisms behind the acetaminophen- and NSAID-prevention of the ovarian cancer. Neoplasma 51(4):239–247
Altinoz MA, Ozpinar A (2019) PPAR-δ and erucic acid in multiple sclerosis and Alzheimer’s disease. Likely benefits in terms of immunity and metabolism. Int Immunopharmacol 69:245–256. https://doi.org/10.1016/j.intimp.2019.01.057
Altinoz MA, Bilir A, Elmaci İ (2018) Erucic acid, a component of Lorenzo’s oil and PPAR-δ ligand modifies C6 glioma growth and toxicity of doxorubicin. Experimental data and a comprehensive literature analysis. Chem Biol Interact 294:107–117. https://doi.org/10.1016/j.cbi.2018.08.024
Bhatia B, Potts CR, Guldal C, Choi S, Korshunov A, Pfister S, Kenney AM, Nahlé ZA (2012) Hedgehog-mediated regulation of PPARγ controls metabolic patterns in neural precursors and shh-driven medulloblastoma. Acta Neuropathol 123:587–600. https://doi.org/10.1007/s00401-012-0968-6
Bierenbaum ML, Chen Y, Lei H, Watkins T (1992) Relationship between dietary fatty acid, selenium, and degenerative cardiomyopathy. Med Hypotheses 39:58–62. https://doi.org/10.1016/0306-9877(92)90141-x
Ceglie G, Del Baldo G, Agolini E, Rinelli M, Cacchione A, Del Bufalo F, Vinci M, Carta R, Boccuto L, Miele E, Mastronuzzi A, Locatelli F, Carai A (2020) Cancer predisposition syndromes associated with pediatric high-grade gliomas. Front Pediatr 8:561487. https://doi.org/10.3389/fped.2020.561487
Chen ZY, Kwan KY, Tong KK, Ratnayake WM, Li HQ, Leung SS (1997) Breast milk fatty acid composition: a comparative study between Hong Kong and Chongqing Chinese. Lipids 32:1061–1067. https://doi.org/10.1007/s11745-997-0137-6
Ding X, Han X, Yuan H, Zhang Y, Gao Y (2020) The impact of PPARD and PPARG polymorphisms on glioma risk and prognosis. Sci Rep 10:5140. https://doi.org/10.1038/s41598-020-60996-2
Fernández LT, Ocampo-Garza SS, Elizondo-Riojas G, Ocampo-Candiani J (2021) Basal cell nevus syndrome: an update on clinical findings. Int J Dermatol. https://doi.org/10.1111/ijd.15884
Girardi F, Rous B, Stiller CA, Gatta G, Fersht N, Storm HH, Rodrigues JR, Herrmann C, Marcos-Gragera R, Peris-Bonet R, Valkov M, Weir HK, Woods RR, You H, Cueva PA, De P, Di Carlo V, Johannesen TB, Lima CA et al (2021) The histology of brain tumors for 67 331 children and 671 085 adults diagnosed in 60 countries during 2000-2014: a global, population-based study (CONCORD-3). Neuro-Oncology 23:1765–1776. https://doi.org/10.1093/neuonc/noab067
Golovko MY, Murphy EJ (2006) Uptake and metabolism of plasma-derived erucic acid by rat brain. J Lipid Res 47(6):1289–1297. https://doi.org/10.1194/jlr.M600029-JLR200
Hua TNM, Oh J, Kim S, Antonio JM, Vo VTA, Om J, Choi JW, Kim JY, Jung CW, Park MJ, Jeong Y (2020) Peroxisome proliferator-activated receptor gamma as a theragnostic target for mesenchymal-type glioblastoma patients. Exp Mol Med 52:629–642. https://doi.org/10.1038/s12276-020-0413-1
Im CN (2017) Combination treatment with PPARγ ligand and its specific inhibitor GW9662 downregulates BIS and 14-3-3 gamma, inhibiting stem-like properties in glioblastoma cells. Biomed Res Int 2017:5832824. https://doi.org/10.1155/2017/5832824
Johnson TE, Holloway MK, Vogel R, Rutledge SJ, Perkins JJ, Rodan GA, Schmidt A (1997) Structural requirements and cell-type specificity for ligand activation of peroxisome proliferator-activated receptors. J Steroid Biochem Mol Biol 63:1–8. https://doi.org/10.1016/s0960-0760(97)00064-2
Kesanakurti D, Maddirela D, Banasavadi-Siddegowda YK, Lai TH, Qamri Z, Jacob NK, Sampath D, Mohanam S, Kaur B, Puduvalli VK (2017) A novel interaction of PAK4 with PPARγ to regulate Nox1 and radiation-induced epithelial-to-mesenchymal transition in glioma. Oncogene. 36:5309–5320. https://doi.org/10.1038/onc.2016.261
Leisewitz AV, Urrutia CR, Martinez GR, Loyola G, Bronfman M (2008) A PPARs cross-talk concertedly commits C6 glioma cells to oligodendrocytes and induces enzymes involved in myelin synthesis. J Cell Physiol 217:367–376. https://doi.org/10.1002/jcp.21509
Li J, Fan Y, Zhang Z, Yu H, An Y, Kramer JK, Deng Z (2009) Evaluating the trans fatty acid, CLA, PUFA and erucic acid diversity in human milk from five regions in China. Lipids. 44:257–271. https://doi.org/10.1007/s11745-009-3282-x
Sun H, Ren Q, Zhao X, Tian Y, Pan J, Wei Q, Li Y, Chen Y, Zhang H, Zhang W, Jiang S (2020) Regional similarities and differences in mature human milk fatty acids in Chinese population: a systematic review. Prostaglandins Leukot Essent Fatty Acids 162:102184. https://doi.org/10.1016/j.plefa.2020.102184
Takahashi A, Dohi H, Egashira Y, Hirai S (2020) Erucic acid derived from rosemary regulates differentiation of mesenchymal stem cells into osteoblasts/adipocytes via suppression of peroxisome proliferator-activated receptor γ transcriptional activity. Phytother Res 34:1358–1366. https://doi.org/10.1002/ptr.6607
Takahashi A, Ishizaki M, Kimira Y, Egashira Y, Hirai S (2021) Erucic acid-rich yellow mustard oil improves insulin resistance in KK-Ay mice. Molecules 26:546. https://doi.org/10.3390/molecules26030546
Vijapura C, Saad Aldin E, Capizzano AA, Policeni B, Sato Y, Moritani T (2017) Genetic syndromes associated with central nervous system tumors. Radiographics 37:258–280. https://doi.org/10.1148/rg.2017160057
Voskamp MJ, Li S, van Daalen KR, Crnko S, Ten Broeke T, Bovenschen N (2021) Immunotherapy in Medulloblastoma: current state of research, challenges, and future perspectives. Cancers (Basel) 13:5387. https://doi.org/10.3390/cancers13215387
Wallingford JC, Yuhas R, Du S, Zhai F, Popkin BM (2004) Fatty acids in Chinese edible oils: value of direct analysis as a basis for labeling. Food Nutr Bull 25:330–336. https://doi.org/10.1177/156482650402500402
Yousefnia S, Momenzadeh S, Seyed Forootan F, Ghaedi K, Nasr Esfahani MH (2018) The influence of peroxisome proliferator-activated receptor γ (PPARγ) ligands on cancer cell tumorigenicity. Gene 649:14–22. https://doi.org/10.1016/j.gene.2018.01.018
Yuhas R, Pramuk K, Lien EL (2006) Human milk fatty acid composition from nine countries varies most in DHA. Lipids 41:851–858. https://doi.org/10.1007/s11745-006-5040-7
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
This is a review study which did not include any human or animal studies. No ethical approval was requested by the local institution.
Conflict of interest
None to declare.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Altinoz, M.A. Could dietary erucic acid lower risk of brain tumors? An epidemiological look to Chinese population with implications for prevention and treatment. Metab Brain Dis 37, 2643–2651 (2022). https://doi.org/10.1007/s11011-022-01022-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-022-01022-4